Medications

Dos and don'ts developed for direct oral anticoagulants

Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions. DOACs are the preferred treatment over vitamin K antagonists (VKAs) for many patients with atrial fibrillation ...

Diseases, Conditions, Syndromes

Adding a P2Y12 inhibitor does not improve outcomes in COVID-19

(HealthDay)—The addition of a P2Y12 inhibitor to anticoagulant therapy does not improve organ support-free days among non-critically ill patients hospitalized for COVID-19, according to a study published in the Jan. 18 ...

page 1 from 7